×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Nymox drama heightens as biotech sues AscellaHealth for $250M in damages
Fierce Biotech
The Nymox Pharmaceutical versus AscellaHealth drama has heightened, with the battle heading to court as Nymox seeks $250 million in damages.
5 months ago
The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues ...
PR Newswire
PRNewswire/ -- The Committee to Restore Nymox Shareholder Value, Inc. ("CRNSV"), with a goal to recover shareholder value in Nymox...
6 months ago
Nymox hits back at mutiny led by former execs
Fierce Biotech
Nymox Pharmaceutical has spoken out against two former leaders who formed a rebellion based on the company's refusal to accept a proposed...
9 months ago
Committee to Restore Nymox Shareholder Value Challenges Nymox CEO Averback to Publish 2022 FDA Refusal To ...
Business Wire
Committee to Restore Nymox Shareholder Value Challenges Nymox CEO Averback to Publish 2022 FDA Refusal To File Correspondence Received May...
9 months ago
AscellaHealth accused of corporate espionage in $250M lawsuit filed by publicly traded biopharma firm - Philadelphia ...
The Business Journals
In the $250 million lawsuit, the California company alleges AscellaHealth used connections inside Nymox in an attempt "to take control of...
4 months ago
The Committee to Restore Nymox Shareholder Value Provides Factual Update to Nymox Shareholders Regarding ...
Yahoo Finance
CARSON CITY, Nev. & LONDON, November 06, 2023--The Committee to Restore Nymox Shareholder Value, Inc. ("CRNSV"), with a goal to recover...
5 months ago
The Committee to Restore Nymox Shareholder Value Soundly Rebuts Injurious Allegations Made by Nymox ...
Business Wire
The Committee to Restore Nymox Shareholder Value, LLC (CRNSV), with a goal to recover shareholder value in NYMOX PHARMACEUTICAL CORP (
9 months ago
Nymox CEO calls ex-staffers' rebellion 'transparent mischief'
Fierce Biotech
Nymox's CEO has called the rebellion by several ex-staffers "transparent mischief" as Bahamas litigation comes to a close.
1 month ago
Nymox tanks as FDA rejects NDA for fexapotide
The Pharma Letter
Nymox tanks as FDA rejects NDA for fexapotide.
23 months ago
Nymox slumps as FDA rejects filing for prostate drug
Pharmaphorum
Shares in US biotech Nymox Pharma have plunged after the company announced the FDA had refused to accept its marketing application for its...
23 months ago